Rex Bionics – Confirmation of Strategic Investment by Maxhealth

05 August 2016: Rex Bionics plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is today pleased to announce that Maxhealth Medicine Co. Ltd has now deposited £1 million in escrow in relation to its subscription for 3,333,333 ordinary shares at 30p each.  This £1 million will be released from escrow and become available to the Company upon admission of the shares to trading. The Company has also received commitment for a further subscription of £225,000 for 750,000 ordinary shares of 30p each from Hunter Hall Investment Management Limited.

More info here.